ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.2614G>T (p.Glu872Ter)

dbSNP: rs190765116
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Human Genetics, University of Leuven RCV000768475 SCV000886763 likely pathogenic Hypertrophic cardiomyopathy 2018-10-31 criteria provided, single submitter clinical testing
Ambry Genetics RCV004027156 SCV005033772 pathogenic Cardiovascular phenotype 2024-01-23 criteria provided, single submitter clinical testing The p.E872* pathogenic mutation (also known as c.2614G>T), located in coding exon 26 of the MYBPC3 gene, results from a G to T substitution at nucleotide position 2614. This changes the amino acid from a glutamic acid to a stop codon within coding exon 26. This alteration has been reported in association with hypertrophic cardiomyopathy (HCM) (Robyns T et al. Eur J Med Genet, 2020 Mar;63:103754; Harper AR et al. Nat Genet, 2021 Feb;53:135-142). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.